Market Intelligence Center  Aug 12  Comment 
Odyssey Healthcare (NASDAQ: ODSY) hit a new 52-Week high of $.00 so far today. Currently the stock is up $0.12 (0.43%) to $26.97 on 1,776,566 shares traded. Today's high is up $15.28 from a 52-Week Low of $11.69. Odyssey Healthcare stock has been...
StreetInsider.com  Jul 28  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Odyssey+Healthcare+Inc.+%28ODSY%29+Posts+Q2+EPS+of+%240.41%2C+Tops+by+3c/5842966.html for the full story.
New York Times  Jul 21  Comment 
The Deal Professor examines some developments involving Novartis's proposed acquisition of Alcon and Gentiva Health Services' acquisition of Odyssey Healthcare that might have been overlooked in the rush of financial news.
StreetInsider.com  Jul 19  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Guidance/Odyssey+HealthCare+%28ODSY%29+Expects+Q2+EPS+of+%240.39+-+%240.41%2C+In-Line+with+Consensus/5816109.html for the full story.
Market Intelligence Center  Jul 1  Comment 
Odyssey Healthcare (ODSY) appears to be trading at a higher than usual volume today and is now at $26.27, down $0.45 (-1.68%) on volume of 2,544,626 shares traded. For the last 30 days ODSY has traded 1,779,640 shares on average each day. So far...
newratings.com  May 25  Comment 
NEW YORK, May 25 (newratings.com) - Analysts at RBC Capital Markets downgrade Odyssey Healthcare Inc (ticker: ODSY) from "outperform" to "sector perform." The target price has been raised from $22 to $27. [more]
Stock Blog Hub  May 25  Comment 
Odyssey HealthCare, Inc. (ODSY) estimates are soaring after the most recent earnings surprise. Company Description Odyssey Healthcare, Inc. provides hospice care services focused on palliative care for patients with life-limiting illnesses....
Forbes  May 24  Comment 
Hospice care provider surges as traders take shelter in defensive names.
Samurai Trader  May 24  Comment 
Today's leading industry is long term care facilities, a 14 stock group that has only one stock with a market cap over $1 B (BKD at $2.2 B). ODSY is being bought out, and happens to be the third largest in the group, which is where today's...
Globe Newswire  May 24  Comment 
NEW YORK, May 24, 2010 (GLOBE NEWSWIRE) -- Levi & Korsinsky is investigating the Board of Directors of Odyssey Healthcare Inc. ("Odyssey Healthcare" or the "Company") (Nasdaq:ODSY) for possible breaches of fiduciary duty and other violations of state


Related Articles


Odyssey HealthCare, Inc. (ODSY), headquartered in Dallas, Texas, is the second largest provider of hospice services in terms of number of locations in the U.S. The provider is one of only two publicly traded pure-play hospice providers. Odyssey was founded in 1995 and has since expanded rapidly through acquisitions and de novo openings to its current portfolio of 81 Medicare-certified hospice programs in 30 states. By state, Odyssey's greatest numbers of hospice facilities are in Texas, California, Arizona and Ohio. The company provides for all medical and psychosocial care, as well as certain other support services associated with patients' terminal illnesses. Odyssey's service offerings include Routine Home Care, General Inpatient Care, Continuous Home Care, and Respite Care.

The bulk of Odyssey's revenues (greater than 90%) are derived from government reimbursements under Medicare and Medicaid. Medicare is the national health insurance program for people age 65 or older. Medicaid is a state-run program that pays for medical assistance for certain individuals and families with low incomes and resources. Under the Medicare Hospice benefit, a patient waives Medicare coverage for treatment of a terminal illness to receive palliative treatment, which helps ease pain and symptoms instead of trying to cure a disease. The benefit reimburses for hospice services that are delivered in freestanding hospice facilities, hospitals, nursing homes, and other long-term care facilities. However, the benefit does not cover expenses for room and board. In some instances, Medicaid may cover these expenses for eligible patients. Medicare limits the amount of payment hospice companies can receive for inpatient care services. Overall, payments made by Medicare to hospice providers are subject to a cap amount per beneficiary (typically 160 days of routine care). Payments in excess of the cap amount must be returned to Medicare. The cap is calculated by taking the average of the entire patient base of a specific local provider. Under the so-called "80-20" rule, if the number of inpatient care days furnished to Medicare beneficiaries exceeds 20% of the total days of hospice care, Medicare payments for days exceeding the inpatient cap is reduced to the routine home care rate.


Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki